No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

MARVIN RUBENSTEIN; COURTNEY M.P. HOLLOWELL; PATRICK GUINAN

Research ArticleExperimental Studies

No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL and PATRICK GUINAN

In Vivo November 2012, 26 (6) 937-940;

MARVIN RUBENSTEIN

1Division of Cellular Biology, Hektoen Institute for Medical Research, Chicago, IL, U.S.A.

2Division of Urology, Stroger Hospital of Cook County, Chicago, IL, U.S.A.

3Department of Biochemistry, Rush University Medical Center

4Department of Urology, Rush University Medical Center

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: DrMarv{at}Prodigy.net

COURTNEY M.P. HOLLOWELL

2Division of Urology, Stroger Hospital of Cook County, Chicago, IL, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

PATRICK GUINAN

1Division of Cellular Biology, Hektoen Institute for Medical Research, Chicago, IL, U.S.A.

2Division of Urology, Stroger Hospital of Cook County, Chicago, IL, U.S.A.

4Department of Urology, Rush University Medical Center

5Department of Urology, University of Illinois at Chicago, Chicago, IL, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Unchanged VEGF expression.

Tables

Figures

PreviousNext

In this issue

In Vivo

Vol. 26, Issue 6

November-December 2012

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

Message Subject (Your Name) has sent you a message from In Vivo

Message Body (Your Name) thought you would like to see the In Vivo web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 12 + 7 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL, PATRICK GUINAN

In Vivo Nov 2012, 26 (6) 937-940;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL, PATRICK GUINAN

In Vivo Nov 2012, 26 (6) 937-940;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation
No Compensation in CD44 Stem Cell Marker Following BCL-2 Suppression By Antisense Oligonucleotides

Google Scholar

Keywords

Antisense
Bcl-2
prostate cancer
VEGF

Main menu

User menu

Search

No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords